Combination therapy for osteoporosis: a reappraisal
نویسندگان
چکیده
منابع مشابه
Osteoporosis: combination therapy for better or worse.
Osteoporosis is a condition that is associated with an increased susceptibility for fractures. In the past few years, several drugs have become available that can reduce the incidence of fractures in patients with osteoporosis. Since these drugs work through different cellular mechanisms, combining agents of different classes may have an additive or multiplicative effect on fracture risk reduct...
متن کاملCell Therapy for Refractory Angina: A Reappraisal
Cardiac cell-based therapy has emerged as a novel therapeutic option for patients dealing with untreatable refractory angina (RA). However, after more than a decade of controlled studies, no definitive consensus has been reached regarding clinical efficacy. Although positive results in terms of surrogate endpoints have been suggested by early and phase II clinical studies as well as by meta-ana...
متن کاملCEREBRAL HYDATIDOSIS: A REAPPRAISAL
The remarkable evolution of surgical management of cerebral hydatidosis towards an earlier diagnosis and proper treatment is evident from this 22-year retrospective study of our experience with 19 cases seen at Shiraz University Medical Institutions. Both cases of iatrogenically-induced infected cysts were seen during the pre-CT era. The optimistic view of being able to remove all the cyst...
متن کاملFluoride Therapy for Vertébral Osteoporosis
Vertébral osteoporosis is characterized by a prédominant atrophy of spongy bone inducing non-traumatic vertébral fractures. Because a low bone mass is the major déterminant of fracture risk, the idéal therapy for established vertébral osteoporosis should increase trabecular bone mass substantially, thereby decreasing the risk of new crush fractures. This idéal treatment should also be capable o...
متن کاملAnabolic skeletal therapy for osteoporosis.
Antiresorptive agents for osteoporosis are a cornerstone of therapy, but anabolic drugs have recently widened our therapeutic options. By directly stimulating bone formation, anabolic agents reduce fracture incidence by improving bone qualities besides increasing bone mass. In this article, we review the role of anabolic treatment for osteoporosis. The only anabolic agent currently approved in ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BoneKEy Reports
سال: 2014
ISSN: 2047-6396
DOI: 10.1038/bonekey.2014.13